Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dalteparin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05993533
What this trial is testing

Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy

Who this might be right for
Venous Thromboembolic Disease
Direction Centrale du Service de Santé des Armées 100
Not applicableStudy completedNCT06038682
What this trial is testing

Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure

Who this might be right for
ARDSCOVID-19
University Hospital Ostrava 100
Not applicableLooking for participantsNCT07200674
What this trial is testing

Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma

Who this might be right for
Hypertriglyceridemia
University Hospital, Strasbourg, France 150
Not applicableStudy completedNCT01029743
What this trial is testing

Xarelto Regulatory Post-Marketing Surveillance

Who this might be right for
Venous Thromboembolism
Bayer 3,388
Not applicableLooking for participantsNCT07384013
What this trial is testing

Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Who this might be right for
Oncologic DiseasesCoagulation DefectPain Management
Rambam Health Care Campus 30
Large-scale testing (Phase 3)Study completedNCT00135876
What this trial is testing

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Who this might be right for
Venous ThromboembolismBrain Tumors
Ontario Clinical Oncology Group (OCOG) 512
Post-approval studies (Phase 4)Study completedNCT00806403
What this trial is testing

Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Sahlgrenska University Hospital 205
Not applicableUnknownNCT03171727
What this trial is testing

Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction

Who this might be right for
Liver CirrhosisPortal Hypertension
West China Hospital 117
Not applicableStudy completedNCT00358735
What this trial is testing

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

Who this might be right for
Deep Vein Thrombosis of Lower LimbPulmonary Embolism (PE)Bleeding
Medical Compression Systems 411
Large-scale testing (Phase 3)Study completedNCT00765063
What this trial is testing

The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)

Who this might be right for
Diabetic Foot Ulcer
Pfizer 62
Post-approval studies (Phase 4)UnknownNCT00196417
What this trial is testing

The HIT-TRAP Trial

Who this might be right for
Heparin-Induced Thrombocytopenia
University Medicine Greifswald 600
Not applicableStudy completedNCT02855047
What this trial is testing

The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations

Who this might be right for
Antiphospholipid Syndrome
Centre Hospitalier Universitaire de Nīmes 513
Not applicableStudy completedNCT06382584
What this trial is testing

Impact of Treatment With Oral Anticoagulants of Patients With Fractures of the Upper End of the Femur

Who this might be right for
Direct Oral Anticoagulants (DOACs)Femoral FracturesSurgery
Centre Hospitalier Universitaire de Nīmes 610
Early research (Phase 1)Study completedNCT00629733
What this trial is testing

Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers

Who this might be right for
Healthy
Rovi Pharmaceuticals Laboratories 12
Not applicableWithdrawnNCT05554055
What this trial is testing

Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)

Who this might be right for
Aortic DiseasesArterial DiseaseThrombosis
Hospices Civils de Lyon
Not applicableLooking for participantsNCT06575309
What this trial is testing

THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin

Who this might be right for
Pregnant WomenVenous Thromboembolic Disease
University Hospital, Clermont-Ferrand 50
Not applicableStudy completedNCT00629447
What this trial is testing

Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

Who this might be right for
Primary Brain Tumor
Duke University 40
Large-scale testing (Phase 3)Ended earlyNCT04558892
What this trial is testing

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.

Who this might be right for
Nephrotic Syndrome
Military Institute od Medicine National Research Institute 65
Not applicableUnknownNCT00354796
What this trial is testing

The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin

Who this might be right for
Acute Coronary SyndromeVenous ThromboembolismAtrial Fibrillation+1 more
Hadassah Medical Organization 500
Large-scale testing (Phase 3)Study completedNCT00951574
What this trial is testing

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Who this might be right for
Advanced CancerMetastatic Cancer
Italfarmaco 1,166
Next Page